188 results
Page 3 of 10
8-K
EX-10.14
v6t0lkkkza9xw1
1 May 20
Entry into a Material Definitive Agreement
4:39pm
8-K
EX-10.16
yscpv
23 Apr 20
Alimera Sciences Receives $1.8 Million Loan
8:58am
8-K
EX-10.14
0qvtprs
23 Apr 20
Alimera Sciences Receives $1.8 Million Loan
8:58am
8-K
EX-10.17
15l8ca xe
23 Apr 20
Alimera Sciences Receives $1.8 Million Loan
8:58am
8-K
EX-10.65
iqeawakt723j 6f55ua
6 Jan 20
Entry into a Material Definitive Agreement
8:25am
8-K
EX-10.66
b6fjpqxkmh9 iu
6 Jan 20
Entry into a Material Definitive Agreement
8:25am
8-K
EX-10.64
3c0qy3
25 Oct 19
Alimera Sciences Announces Equity Purchase Agreement for up to
9:00am
8-K
EX-10.63
g3enrh4swis2 shcjs
5 Sep 19
Alimera Sciences Board of Directors Approves Reverse Stock Split and 10b5-1 Stock Purchase Plan for U.S. Executive Management
8:20am
8-K
EX-10.62
tshds0
19 Jul 19
Alimera Sciences Announces the Appointment of Industry Veteran and Ophthalmology Business Executive John Snisarenko to its Board of Directors
9:03am
8-K
EX-10.61
q0rkiha eqtt4q
19 Jun 19
Departure of Directors or Certain Officers
5:21pm
8-K
EX-10.60
7x76g3
19 Jun 19
Departure of Directors or Certain Officers
5:21pm
8-K
EX-10.59
dydsa4 lh
8 May 19
Departure of Directors or Certain Officers
4:32pm
8-K
EX-10.58
gl3xb5 7z
8 May 19
Departure of Directors or Certain Officers
4:32pm
8-K
EX-10.2
yevabm0dad1 xj
29 Nov 18
Alimera Sciences Appoints Rick Eiswirth as Chief Executive Officer
8:33am
8-K
EX-10.1
5rzmvovige aa4
29 Nov 18
Alimera Sciences Appoints Rick Eiswirth as Chief Executive Officer
8:33am
8-K
EX-10.1
umubs
5 Sep 18
Alimera Sciences Announces Exchange of Series B Preferred Stock for Newly Issued Series C Preferred Stock
12:00am
8-K
EX-10.1
cw87d
8 Jan 18
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.2
5tfcxf45iei
8 Jan 18
Entry into a Material Definitive Agreement
12:00am